Locust Wood Capital Advisers’s Allergan plc AGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2016
Q4
Sell
-100,200
Closed -$23.1M 47
2016
Q3
$23.1M Buy
100,200
+82,375
+462% +$20.1M 2.66% 16
2016
Q2
$4.12M Sell
17,825
-127,491
-88% -$29.4M 0.46% 38
2016
Q1
$38.9M Buy
145,316
+2,979
+2% +$853K 4.14% 7
2015
Q4
$44.5M Sell
142,337
-2,243
-2% -$668K 5.5% 3
2015
Q3
$39.3M Buy
+144,580
New +$44.4M 5.31% 3
2015
Q2
Sell
-26,960
Closed -$8.02M 49
2015
Q1
$8.02M Buy
+26,960
New +$7.69M 1.01% 31

Other funds holding AGN

Locust Wood Capital Advisers's AGN Position: Q4 2016 in Review

Locust Wood Capital Advisers sold out of Allergan plc (AGN) in Q4 2016, closing a stake of 100,200 shares — an estimated $23.1M sold.

Locust Wood Capital Advisers first reported a position in AGN in Q1 2015 and held it in 6 quarters. The position peaked at $44.5M in Q4 2015. 1,091 funds tracked by Wall St. Rank hold AGN as of Q4 2016.

  • Locust Wood Capital Advisers reported no remaining Allergan plc position as of Q4 2016 after selling out during the quarter.
  • Locust Wood Capital Advisers sold 100,200 Allergan plc shares in Q4 2016, an estimated $23.1M.
  • Locust Wood Capital Advisers first reported a position in Allergan plc in Q1 2015 and held it in 6 quarters.
  • Locust Wood Capital Advisers's Allergan plc position peaked at $44.5M in Q4 2015.
  • 1,091 funds tracked by Wall St. Rank held Allergan plc as of Q4 2016.

Based on Locust Wood Capital Advisers's 13F filing for Q4 2016, filed 3 Feb 2017.